Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 166
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
BMC Plant Biol ; 23(1): 90, 2023 Feb 13.
Artículo en Inglés | MEDLINE | ID: mdl-36782110

RESUMEN

BACKGROUND: In seed plants, the ovule is the precursor to the seed. The process of ovule development and differentiation is regulated by multiple factors, including starch metabolism and endogenous hormones. Castanea henryi produces nuts with high nutritional value. However, the high proportion of empty buds restricts the commercial use of the tree. Previous studies have shown that the empty bud phenotype is closely related to ovule abortion. If none of the ovules in the ovary expand rapidly and develop in 7-8 weeks after pollination, an empty bud will form. Therefore, we studied the development and molecular mechanisms underlying single seed formation in C. henryi. RESULTS: We found that 49 days after pollination (DAP) is a critical period for the formation of fertile and abortive ovules. The morphology and starch distribution of the fertile and abortive ovules differed significantly at 49 DAP. The fertile ovules were smooth and round in appearance, with a large amount of starch. In contrast, abortive ovules were smaller with only a small amount of starch. The embryo sac of the abortive ovule proceeded to develop abnormally, and the entire ovule lacked starch. We identified 37 candidate genes involved in metabolism with potential roles in the regulation of starch levels. Three ADP-glucose pyrophosphorylase (AGPase) genes, one granule-bound starch synthase (GBSS) gene, and two beta-amylase genes could affect starch accumulation. The levels of auxin, cytokinins, gibberellins, and jasmonic acid in fertile ovules were higher than those in abortive ovules. In addition, the levels of endogenous abscisic acid and salicylic acid in abortive ovules were higher than those in fertile ovules of the same age, consistent with the expression patterns of genes related to the synthesis of abscisic and salicylic acid and signal transduction. We identified and mapped the differentially expressed genes associated with hormone synthesis and signal transduction. CONCLUSIONS: These results improve our general understanding of the molecular mechanisms underlying single seed development in C. henryi and the phenomenon of empty buds, providing directions for future research.


Asunto(s)
Perfilación de la Expresión Génica , Transcriptoma , Semillas , Almidón/metabolismo , Hormonas/metabolismo , Óvulo Vegetal , Regulación de la Expresión Génica de las Plantas
2.
Small ; 19(30): e2300431, 2023 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-37029575

RESUMEN

Silicon (Si) anode suffers from huge volume expansion which causes poor structural stability in terms of electrode material, solid electrolyte interface, and electrode, limiting its practical application in high-energy-density lithium-ion batteries. Rationally designing architectures to optimize the stress distribution of Si/carbon (Si/C) composites has been proven to be effective in enhancing their structural stability and cycling stability, but this remains a big challenge. Here, metal-organic frameworks (ZIF-67)-derived carbon nanotube-reinforced carbon framework is employed as an outer protective layer to encapsulate the inner carbon-coated Si nanoparticles (Si@C@CNTs), which features dual carbon stress-buffering to enhance the structural stability of Si/C composite and prolong their cycling lifetime. Finite element simulation proves the structural advantage of dual carbon stress-buffering through significantly relieving stress concentration when Si lithiation. The outer carbon framework also accelerates the charge transfer efficiency during charging/discharging by the improvement of lithium-ion diffusion and electron transport. As a result, the Si@C@CNTs electrode exhibits excellent long-term lifetime and good rate capability, showing a specific capacity of 680 mAh g-1 even at a high rate of 1 A g-1 after 1000 cycles. This work provides insight into the design of robust architectures for Si/C composites by stress optimization.

3.
Kidney Int ; 102(6): 1320-1330, 2022 12.
Artículo en Inglés | MEDLINE | ID: mdl-36007598

RESUMEN

Hemopexin, a heme scavenging protein, accumulates in the kidneys during acute kidney injury (AKI). However, the function of this accumulated hemopexin in the kidney is unclear. In both the cisplatin-induced and the unilateral kidney ischemia-reperfusion injury models of AKI, we found accumulation of hemoglobin and hemopexin in the kidneys localized to the proximal tubules. Next, hemopexin wild-type and knockout mice were compared in both AKI models and hemopexin wild type mice had significantly worse kidney injury. Furthermore, there was increased kidney expression of kidney injury molecule-1 (a biomarker of AKI) and heme oxygenase-1 (an indicator of oxidative stress) in hemopexin wild type compared with knockout mice in both models of AKI. Next, the interaction of hemopexin and hemoglobin in vitro was investigated using cultured proximal tubular cells. Co-incubation of hemopexin with hemoglobin resulted in hemoglobin deposition and exaggerated hemoglobin-induced injury. Deferoxamine, an iron chelator, and ferrostatin-1, a ferroptosis inhibitor, inhibited this deleterious effect of hemoglobin and hemopexin in proximal tubular cells, implicating iron toxicity in the mechanism of hemopexin mediated injury. Furthermore, the protective effect of deferoxamine in cisplatin-induced AKI was apparent in hemopexin wild type, but not in hemopexin knockout mice, further implicating hemopexin as a mediator of iron toxicity in AKI. Thus, our findings demonstrate that hemopexin accumulates in the kidneys and worsens kidney injury in AKI by increasing hemoglobin deposition on proximal tubular cells to exaggerate hemoglobin-induced cell injury.


Asunto(s)
Lesión Renal Aguda , Hemopexina , Ratones , Animales , Hemopexina/metabolismo , Cisplatino/toxicidad , Deferoxamina , Lesión Renal Aguda/etiología , Túbulos Renales Proximales/metabolismo , Riñón/metabolismo , Ratones Noqueados , Hemoglobinas/metabolismo , Hierro/efectos adversos , Ratones Endogámicos C57BL , Túbulos Renales/metabolismo
4.
Cell Biol Int ; 46(8): 1227-1235, 2022 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-35419903

RESUMEN

A better understanding of the molecular regulation of wound healing may provide novel therapeutic targets. A previous study revealed that junctional adhesion molecule A (JAM-A)-modified mesenchymal stem cells promoted wound healing. However, whether direct JAM-A modification in the skin wound edge area accelerates the wound repair process is not clear. We determined whether JAM-A modification at the skin wound edge accelerated the wound healing process. We established JAM-A modification mouse wound models and mouse primary fibroblast cell models. Wound pictures were taken to compare the wound size. H&E staining was performed to monitor the morphology of the wound and quality of the newborn skin. CCK-8 assays and immunofluorescence (IF) for Ki67 were used to measure the cell proliferation of mouse primary fibroblasts. Quantitative real-time PCR, immunohistochemistry, IF, and Western blot analysis were used to detect bFGF and EGF expression in vivo and in vitro. The JAM-A-overexpressing group exhibited a smaller residual wound size than the control group at Day 7. Thicker epidermal layers and more hair follicle-like structures were found in the JAM-A-overexpressing group at Day 21. Cell proliferation capacity was higher in JAM-A-modified mouse fibroblasts. Elevated levels of bFGF and EGF were found in the JAM-A-modified group in vivo and in vitro. JAM-A modification significantly promoted fibroblast proliferation and wound healing. Increased levels of bFGF and EGF growth factors may be part of the mechanism.


Asunto(s)
Molécula A de Adhesión de Unión , Animales , Proliferación Celular , Modelos Animales de Enfermedad , Factor de Crecimiento Epidérmico/metabolismo , Fibroblastos/metabolismo , Molécula A de Adhesión de Unión/metabolismo , Lentivirus , Ratones , Piel/metabolismo , Cicatrización de Heridas/fisiología
5.
Int J Mol Sci ; 23(12)2022 Jun 07.
Artículo en Inglés | MEDLINE | ID: mdl-35742833

RESUMEN

Castanea henryi is a monoecious plant with a low female-to-male ratio, which limits its yield. The phytohormone cytokinin (CK) plays a crucial role in flower development, especially gynoecium development. Here, the feminizing effect of CK on the development of C. henryi was confirmed by the exogenous spraying of N-(2-chloro-4-pyridyl)-N'-phenylurea (CPPU). Spraying CPPU at 125 mg·L-1 thrice changed the male catkin into a pure female catkin, whereas at 5 mg·L-1 and 25 mg·L-1, only a part of the male catkin was transformed into a female catkin. A comparative transcriptome analysis of male catkins subjected to CPPU was performed to study the mechanism of the role of CKs in sex differentiation. Using Pearson's correlation analysis between hormone content and hormone synthesis gene expression, four key genes, LOG1, LOG3, LOG7 and KO, were identified in the CK and GA synthesis pathways. Moreover, a hub gene in the crosstalk between JA and the other hormone signaling pathways, MYC2, was identified, and 15 flowering-related genes were significantly differentially expressed after CPPU treatment. These results suggest that CK interacts with other phytohormones to determine the sex of C. henryi, and CK may directly target floral organ recognition genes to control flower sex.


Asunto(s)
Citocininas , Fagaceae , Citocininas/metabolismo , Fagaceae/genética , Feminización/metabolismo , Flores/metabolismo , Perfilación de la Expresión Génica/métodos , Regulación de la Expresión Génica de las Plantas , Hormonas/metabolismo , Humanos , Masculino , Reguladores del Crecimiento de las Plantas/metabolismo , Transcriptoma
6.
J Cell Mol Med ; 24(9): 5224-5237, 2020 05.
Artículo en Inglés | MEDLINE | ID: mdl-32233073

RESUMEN

Liver fibrosis, a consequence of unhealthy modern lifestyles, has a growing impact on human health, particularly in developed countries. Here, we have explored the anti-fibrotic effects of propylene glycol alginate sodium sulphate (PSS), a natural extract from brown algae, in fibrotic mice and cell models. Thus, we established bile duct ligature and carbon tetrachloride mouse models and LX-2 cell models with or without PSS treatment. Liver pathological sections and the relevant indicators in serum and liver tissues were examined. PSS prevented hepatic injury and fibrosis to a significant extent, and induced up-regulation of matrix metalloproteinase-2 and down-regulation of tissue inhibitor of metalloproteinase-1 through suppressing the transforming growth factor ß1 (TGF-ß1)/Smad pathway. PSS additionally exerted an anti-autophagy effect through suppressing the Janus kinase (JAK) 2/transducer and activator of transcription 3 (STAT3) pathway. In conclusion, PSS prevents hepatic fibrosis by suppressing inflammation, promoting extracellular matrix (ECM) decomposition and inactivating hepatic stellate cells through mechanisms involving the TGF-ß1/Smad2/3 and JAK2/STAT3 pathways in vivo and in vitro.


Asunto(s)
Alginatos/uso terapéutico , Quinasas Janus/metabolismo , Cirrosis Hepática/tratamiento farmacológico , Cirrosis Hepática/metabolismo , Factores de Transcripción STAT/metabolismo , Transducción de Señal , Proteínas Smad/metabolismo , Factor de Crecimiento Transformador beta/metabolismo , Alginatos/farmacología , Animales , Autofagia/efectos de los fármacos , Conductos Biliares/patología , Tetracloruro de Carbono , Modelos Animales de Enfermedad , Regulación hacia Abajo/efectos de los fármacos , Regulación hacia Abajo/genética , Células Estrelladas Hepáticas/efectos de los fármacos , Células Estrelladas Hepáticas/metabolismo , Células Estrelladas Hepáticas/patología , Ligadura , Cirrosis Hepática/enzimología , Cirrosis Hepática/patología , Masculino , Metaloproteinasa 2 de la Matriz/metabolismo , Ratones Endogámicos C57BL , Modelos Biológicos , Inhibidor Tisular de Metaloproteinasa-1/metabolismo , Regulación hacia Arriba/efectos de los fármacos
7.
Opt Express ; 28(22): 32750-32763, 2020 Oct 26.
Artículo en Inglés | MEDLINE | ID: mdl-33114953

RESUMEN

Super-resolution imaging based on single molecule localization of cellular structures on nanometer scale requires to record a series of wide-field or TIRF images resulting in a considerable recording time (typically of minutes). Therefore, sample drift becomes a critical problem and will lower the imaging precision. Herein we utilized morphological features of the specimen (mammalian cells) itself as reference markers replacing the traditionally used markers (e.g., artificial fiduciary markers, fluorescent beads, or metal nanoparticles) for sample drift compensation. We achieved sub-nanometer localization precision <1.0 nm in lateral direction and <6.0 nm in axial direction, which is well comparable with the precision achieved with the established methods using artificial position markers added to the specimen. Our method does not require complex hardware setup, extra labelling or markers, and has the additional advantage of the absence of photobleaching, which caused precision decrease during the course of super-resolution measurement. The achieved improvement of quality and resolution in reconstructed super-resolution images by application of our drift-correction method is demonstrated by single molecule localization-based super-resolution imaging of F-actin in fixed A549 cells.


Asunto(s)
Procesamiento de Imagen Asistido por Computador/métodos , Imagenología Tridimensional/instrumentación , Microscopía Fluorescente/instrumentación , Nanoestructuras , Nanotecnología/instrumentación , Células A549 , Diseño de Equipo , Humanos
8.
Langmuir ; 36(45): 13555-13562, 2020 Nov 17.
Artículo en Inglés | MEDLINE | ID: mdl-33140641

RESUMEN

Cost-effective transition metal chalcogenides have aroused wide consideration as alternative anode materials in lithium ion batteries (LIBs) on account of their elevated lithium activity and considerable theoretical capacity. However, the significant challenge caused by the large volume change and shuttle effect of polysulfides during Li ion insertion/extraction severely restricts their practical application. In this work, the uniform MnO2 coating layer with a tunable thickness on Ni3S2 nanorod arrays has been achieved through a mild oriented-redox reaction by taking advantage of the mixing valence of Ni in Ni3S2 [(Ni2+)2(Ni0)(S2-)2]. The core/shell structured nanorod arrays directly used as anode materials of LIBs demonstrate remarkably improved lithium storage performance including high rate capacity and long cycle life, which deliver a discharge capacity of 662 mA h g-1 for 150 cycles at 0.5 C, corresponding to an elevated capacity retention of 90.7%. The improved electrochemical performances can be assigned to the generation of stable solid electrolyte interface films and suppression of the shuttle behavior with the protection of the MnO2 coating layer on Ni3S2 nanorod arrays.

9.
Inorg Chem ; 59(12): 8522-8531, 2020 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-32463675

RESUMEN

The search for cost-effective and highly active transition-metal-based electrocatalysts is of great importance for overall water splitting to generate clean energy hydrogen. In this work, we present a controllable structural transformation engineering strategy to construct 3D hierarchical CoP porous microscale prism-like superstructure (assembled with nanoflakes) arrays grown on surface-phosphatized Ni foam (CoP/SPNF). Specifically, Zn/Co-based composite arrays with a nanowires@prism hierarchical structure were prepared on Ni foam first. Then, porous Co-based compound arrays with a nanoflakes@prism hierarchical structure were obtained through removing the Zn-based compound by alkaline etching. Finally, CoP arrays were produced through phosphatization of the prepared Co-based array precursor, using NaH2PO2·H2O as the P source. The fabricated CoP/SPNF electrocatalyst exhibits impressive bifunctional performance for the hydrogen evolution reaction (HER, overpotential of 45 mV at 10 mA cm-2) and oxygen evolution reaction (OER, overpotential of 215 mV at 80 mA cm-2) and consequently enables efficient electrolytic water splitting with a low cell voltage of 1.547 V at 30 mA cm-2 and a prominent durability. Versatile CoP with its porous superstructure arrays on surface-phosphatized Ni foam can increase the exposure of electrochemically active sites and render easy contact with the electrolyte, thus facilitating fast electron transport and effective electrolyte diffusion during the electrocatalytic process, as well as promoting the release of product gas bubbles from the electrode. This work provides an effective strategy for the design and preparation of non-noble-metal bifunctional electrocatalysts for overall water splitting electrolysis.

10.
Appl Microbiol Biotechnol ; 104(19): 8231-8242, 2020 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-32816087

RESUMEN

Oncolytic virus (OV) immunotherapy is characterized by viruses which specifically target cancer cells and cause their cytolysis. They provide a unique and promising new tool for the eradication of cancer as they interact with and affect the tumor microenvironment (TME), vasculature, and immune system. Advancements of genetic engineering have allowed for these viruses to be armed in such a way to have enhanced targeting, strong immunomodulation properties, and an ability to modify the TME. However, there are still major limitations in their use, mostly due to difficulties in delivering the viral particles to the tumors and in ensuring that the immunomodulatory properties are able to stimulate the host immune response to mount a complete response. Using novel delivery systems and using OVs as a complementary therapy in a combinatorial treatment have shown some significant successes. In this review, we discuss the major issues and difficulties in using OVs as anti-tumor agents and some of the strategies put in place so far to overcome these limitations. KEY POINTS: • Oncolytic viruses (OVs) infect cancer cells and cause their cytolysis. • The major limitations in using OVs as anti-tumor therapy were discussed. • The potential strategies to overcome these limitations were summarized.


Asunto(s)
Neoplasias , Viroterapia Oncolítica , Virus Oncolíticos , Humanos , Inmunomodulación , Inmunoterapia , Neoplasias/terapia , Virus Oncolíticos/genética , Microambiente Tumoral
11.
Chem Biodivers ; 17(6): e2000135, 2020 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-32249503

RESUMEN

The present study investigated the allelopathic effects of aqueous extracts of Castanea henryi litter on the growth and physiological responses of Brassica pekinensis and Zea mays. Treatment with high concentrations of leaf extract (0.05 g/ml for B. pekinensis and 0.10 g/ml for Z. mays) significantly increased malonaldehyde content and reduced seed germination, seedling growth, chlorophyll content, and the activity levels of antioxidant enzymes. These effects generally increased with increasing extract concentration. However, in Z. mays, low extract concentrations actually promoted seed germination, shoot growth, chlorophyll content, and antioxidant enzyme activity. The allelopathic effects of the various C. henryi extracts decreased as follows: leaf extract > twig extract > shell extract. Eleven potential allelochemicals including rutin, quercetin, luteolin, procyanidin A2, kaempferol, allantoin, propionic acid, salicylic acid, jasmonic acid, methylmalonic acid, and gentisic acid were identified in the leaves of C. henryi which were linked to the strongest allelopathic effects. These findings suggest that the allelopathic effects of C. henryi differ depending on receptor plant species, and that leaves are the most allelopathic litter in C. henryi.


Asunto(s)
Brassica/crecimiento & desarrollo , Fagaceae/química , Feromonas/química , Extractos Vegetales/química , Zea mays/crecimiento & desarrollo , Brassica/efectos de los fármacos , Catalasa/metabolismo , Clorofila/metabolismo , Fagaceae/metabolismo , Germinación/efectos de los fármacos , Feromonas/farmacología , Extractos Vegetales/farmacología , Proteínas de Plantas/metabolismo , Raíces de Plantas/efectos de los fármacos , Raíces de Plantas/crecimiento & desarrollo , Plantones/efectos de los fármacos , Superóxido Dismutasa/metabolismo , Zea mays/efectos de los fármacos
12.
J Cell Mol Med ; 23(9): 6479-6493, 2019 09.
Artículo en Inglés | MEDLINE | ID: mdl-31328391

RESUMEN

BACKGROUND: Liver fibrosis is a wound-healing process of liver featured by the over-deposition of extracellular matrix (ECM) and angiogenesis. However, the effective treatment is lacking. Procyanidin B2 (PB2) is a flavonoid extract abundant in grape seeds with anti-oxidant, anti-inflammatory and anti-cancer properties. The present study aimed to determine effects of PB2 on liver fibrosis. METHOD: The CCl4-induced mouse liver fibrosis model and a human hepatic stellate cell (HSC) line (LX2 cells) were used to study the activation, ECM production and angiogenesis of HSCs through Western blotting analysis, immunohistochemistry, immunofluorescence staining, flow cytometry and tubulogenesis assay. A Hedgehog (Hh) pathway inhibitor (cyclopamine) and Smoothened agonist (SAG) were used to investigate the role of PB2 on Hh pathway. RESULTS: The results showed that PB2 could inhibit the proliferation and induce apoptosis of HSCs. PB2 could also down-regulate the expressions of VEGF-A, HIF-1α, α-SMA, Col-1 and TGF-ß1 of HSCs in vivo and in vitro. The application of SAG and cyclopamine proved that PB2 targets on Hh pathway. CONCLUSIONS: PB2 inhibited the Hh pathway to suppress the activation, ECM production and angiogenesis of HSCs, therefore reverses the progression of liver fibrosis in vivo and in vitro.


Asunto(s)
Biflavonoides/farmacología , Catequina/farmacología , Proteínas Hedgehog/metabolismo , Células Estrelladas Hepáticas/efectos de los fármacos , Cirrosis Hepática/tratamiento farmacológico , Neovascularización Patológica/tratamiento farmacológico , Proantocianidinas/farmacología , Transducción de Señal/efectos de los fármacos , Animales , Tetracloruro de Carbono/farmacología , Línea Celular , Proliferación Celular/efectos de los fármacos , Regulación hacia Abajo/efectos de los fármacos , Células Estrelladas Hepáticas/metabolismo , Humanos , Hígado/efectos de los fármacos , Hígado/metabolismo , Cirrosis Hepática/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Morfogénesis/efectos de los fármacos , Neovascularización Patológica/metabolismo , Factor de Crecimiento Transformador beta1/metabolismo , Alcaloides de Veratrum/farmacología
13.
J Gastroenterol Hepatol ; 34(1): 263-276, 2019 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-29864192

RESUMEN

BACKGROUND AND AIM: Liver fibrosis is a worldwide clinical challenge during the progression of chronic liver disease to liver cirrhosis. Shikonin is extracted from the root of Lithospermum erythrorhizon with antioxidant, anti-inflammatory, anticancer, and wound-healing properties. The study aims to investigate the protective effect of shikonin on liver fibrosis and its underlying mechanism. METHODS: Two liver fibrosis models were established in male C57 mice by intraperitoneal injection of CCl4 or bile duct ligation. Shikonin was administered orally three times weekly at a dose of 2.5 or 5 mg/kg. Protein and mRNA expressions were assayed by quantitative real-time polymerase chain reaction, Western blotting, and immunohistochemical staining. RESULTS: Shikonin significantly inhibited activation of hepatic stellate cells and extracellular matrix formation by downregulating the transforming growth factor-ß1 expression and maintaining the normal balance between metalloproteinase-2 and tissue inhibitor of metalloproteinase-1. Shikonin also decreased hepatic stellate cell energy production by inhibiting autophagy. CONCLUSIONS: The results confirmed that shikonin attenuated liver fibrosis by downregulating the transforming growth factor-ß1/Smads pathway and inhibiting autophagy.


Asunto(s)
Antiinflamatorios no Esteroideos/farmacología , Cirrosis Hepática/metabolismo , Cirrosis Hepática/prevención & control , Naftoquinonas/farmacología , Proteínas Smad Reguladas por Receptores/antagonistas & inhibidores , Factor de Crecimiento Transformador beta1/antagonistas & inhibidores , Alanina Transaminasa/sangre , Animales , Antiinflamatorios no Esteroideos/uso terapéutico , Aspartato Aminotransferasas/sangre , Autofagia/efectos de los fármacos , Modelos Animales de Enfermedad , Regulación hacia Abajo/efectos de los fármacos , Matriz Extracelular/metabolismo , Células Estrelladas Hepáticas/fisiología , Cirrosis Hepática/patología , Masculino , Metaloproteinasa 2 de la Matriz/metabolismo , Ratones , Ratones Endogámicos C57BL , Naftoquinonas/uso terapéutico , Transducción de Señal/efectos de los fármacos , Inhibidor Tisular de Metaloproteinasa-1/metabolismo
14.
Mediators Inflamm ; 2019: 3240713, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31316298

RESUMEN

Hepatic ischemia reperfusion (IR) injury (IRI) occurs during liver transplantation, hepatectomy, and hemorrhagic shock. Oleanolic acid (OA) is a natural compound with antioxidant and anti-inflammatory activity that has been used to treat liver disorders in clinical practice for several years. Here, we investigated the effects and underlying mechanisms of OA in hepatic IRI. A 60-minute partial (70%) hepatic, warm, ischemic reperfusion model was established in BALB/c mice, and two doses (30 and 60 mg/kg) of OA were administered intragastrically for 7 consecutive days prior to hepatic IR. Orbital blood and liver specimens were collected at 2, 8, and 24 h after IR. The results showed that OA preconditioning significantly alleviated hepatic injury, as evidenced by decreased alanine aminotransferase and aspartate aminotransferase levels; improved histology, inhibition of JNK phosphorylation, and high mobility group box 1 (HMGB1); and tumor necrosis factor-α downregulation in hepatic IR mice. OA upregulated Bcl-2 and downregulated caspase-3, caspase-9, Bax, Beclin 1, and LC3, which play crucial roles in the regulation of apoptosis and autophagy. These findings highlighted the protective effects of OA against hepatic IRI mediated by the inhibition of apoptosis and autophagy and the release of HMGB1, which acted as a late inflammatory mediator in hepatic IRI.


Asunto(s)
Apoptosis/efectos de los fármacos , Autofagia/efectos de los fármacos , Proteína HMGB1/metabolismo , Ácido Oleanólico/uso terapéutico , Daño por Reperfusión/tratamiento farmacológico , Animales , Hepatectomía , Inflamación , Hígado/patología , Trasplante de Hígado , MAP Quinasa Quinasa 4/metabolismo , Masculino , Ratones , Ratones Endogámicos BALB C , Fosforilación , Transducción de Señal , Acondicionamiento Pretrasplante , Factor de Necrosis Tumoral alfa/metabolismo
16.
Int J Mol Sci ; 19(7)2018 Jul 21.
Artículo en Inglés | MEDLINE | ID: mdl-30037072

RESUMEN

Non-coding RNAs are important regulators of protein-coding genes. The current study characterized an antisense long non-coding RNA, ATP1A1-AS1, which is located on the opposite strand of the Na/K-ATPase α1 gene. Our results show that four splice variants are expressed in human adult kidney cells (HK2 cells) and embryonic kidney cells (HEK293 cells). These variants can be detected in both cytosol and nuclear fractions. We also found that the inhibition of DNA methylation has a differential effect on the expression of ATP1A1-AS1 and its sense gene. To investigate the physiological role of this antisense gene, we overexpressed the ATP1A1-AS1 transcripts, and examined their effect on Na/K-ATPase expression and related signaling function in human kidney cells. The results showed that overexpression of the ATP1A1-AS1-203 transcript in HK2 cells reduced the Na/K-ATPase α1 (ATP1A1) gene expression by approximately 20% (p < 0.05), while reducing the Na/K-ATPase α1 protein synthesis by approximately 22% (p < 0.05). Importantly, overexpression of the antisense RNA transcript attenuated ouabain-induced Src activation in HK2 cells. It also inhibited the cell proliferation and potentiated ouabain-induced cell death. These results demonstrate that the ATP1A1-AS1 gene is a moderate negative regulator of Na/K-ATPase α1, and can modulate Na/K-ATPase-related signaling pathways in human kidney cells.


Asunto(s)
Riñón/metabolismo , ARN sin Sentido/metabolismo , ARN Largo no Codificante/metabolismo , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Western Blotting , Línea Celular , Proliferación Celular/genética , Proliferación Celular/fisiología , Epigénesis Genética/genética , Epigénesis Genética/fisiología , Células HEK293 , Factor Nuclear 3-alfa del Hepatocito/genética , Factor Nuclear 3-alfa del Hepatocito/metabolismo , Humanos , ARN sin Sentido/genética , ARN Largo no Codificante/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Transducción de Señal/genética , Transducción de Señal/fisiología , ATPasa Intercambiadora de Sodio-Potasio/genética
17.
Int J Cancer ; 141(12): 2571-2584, 2017 12 15.
Artículo en Inglés | MEDLINE | ID: mdl-28857200

RESUMEN

Hepatocellular carcinoma (HCC) is one of the few cancers with a continuous increase in incidence and mortality. Drug resistance is a major problem in the treatment of HCC. In this study, two sorafenib-resistant HCC cell lines and a nude mouse subcutaneously tumor model were used to explore the possible mechanisms leading to sorafenib resistance, and to investigate whether aspirin could increase the sensitivity of hepatoma cells to sorafenib. The combination of aspirin and sorafenib resulted in a synergistic antitumor effect against liver tumors both in vitro and in vivo. High glycolysis and PFKFB3 overexpression occupied a dominant position in sorafenib resistance, and can be targeted and overcome by aspirin. Aspirin plus sorafenib induced apoptosis in tumors without inducing weight loss, hepatotoxicity or inflammation. Our results suggest that aspirin overcomes sorafenib resistance and their combination may be an effective treatment approach for HCC.


Asunto(s)
Aspirina/administración & dosificación , Carcinoma Hepatocelular/tratamiento farmacológico , Resistencia a Antineoplásicos/efectos de los fármacos , Neoplasias Hepáticas/tratamiento farmacológico , Niacinamida/análogos & derivados , Compuestos de Fenilurea/administración & dosificación , Fosfofructoquinasa-2/genética , Animales , Aspirina/farmacología , Carcinoma Hepatocelular/genética , Carcinoma Hepatocelular/metabolismo , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Sinergismo Farmacológico , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Glucólisis/efectos de los fármacos , Humanos , Neoplasias Hepáticas/genética , Neoplasias Hepáticas/metabolismo , Ratones , Ratones Desnudos , Niacinamida/administración & dosificación , Niacinamida/farmacología , Compuestos de Fenilurea/farmacología , Fosfofructoquinasa-2/metabolismo , Sorafenib , Ensayos Antitumor por Modelo de Xenoinjerto
18.
Br J Cancer ; 117(10): 1518-1528, 2017 Nov 07.
Artículo en Inglés | MEDLINE | ID: mdl-28926527

RESUMEN

BACKGROUND: Genistein is a natural isoflavone with many health benefits, including antitumour effects. Increased hypoxia-inducible factor 1 α (HIF-1α) levels and glycolysis in tumour cells are associated with an increased risk of mortality, cancer progression, and resistance to therapy. However, the effect of genistein on HIF-1α and glycolysis in hepatocellular carcinoma (HCC) is still unclear. METHODS: Cell viability, apoptosis rate, lactate production, and glucose uptake were measured in HCC cell lines with genistein incubation. Lentivirus-expressed glucose transporter 1 (GLUT1) or/and hexokinase 2 (HK2) and siRNA of HIF-1α were used to test the direct target of genistein. Subcutaneous xenograft mouse models were used to measure in vivo efficacy of genistein and its combination with sorafenib. RESULTS: Genistein inhibited aerobic glycolysis and induced mitochondrial apoptosis in HCC cells. Neither inhibitors nor overexpression of HK2 or GLUTs enhance or alleviate this effect. Although stabiliser of HIF-1α reversed the effect of genistein, genistein no longer has effects on HIF-1α siRNA knockdown HCC cells. In addition, genistein enhanced the antitumour effect of sorafenib in sorafenib-resistant HCC cells and HCC-bearing mice. CONCLUSIONS: Genistein sensitised aerobic glycolytic HCC cells to apoptosis by directly downregulating HIF-1α, therefore inactivating GLUT1 and HK2 to suppress aerobic glycolysis. The inhibitory effect of genistein on tumour cell growth and glycolysis may help identify effective treatments for HCC patients at advanced stages.


Asunto(s)
Antineoplásicos/farmacología , Carcinoma Hepatocelular/tratamiento farmacológico , Genisteína/farmacología , Glucólisis/efectos de los fármacos , Neoplasias Hepáticas/tratamiento farmacológico , Animales , Apoptosis/efectos de los fármacos , Carcinoma Hepatocelular/patología , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Expresión Génica/efectos de los fármacos , Humanos , Neoplasias Hepáticas/patología , Ratones , Ratones Desnudos , Ensayos Antitumor por Modelo de Xenoinjerto
19.
Cell Physiol Biochem ; 43(2): 518-530, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28930716

RESUMEN

BACKGROUND/AIMS: Irritable bowel syndrome (IBS), defined as recurrent abdominal pain and changes in bowel habits, seriously affects quality of life and ability to work. Ghrelin is a brain-gut hormone, which has been reported to show antinociceptive effects in peripheral pain. We investigated the effect of ghrelin on visceral hypersensitivity and pain in a rat model of IBS. METHODS: Maternal deprivation (MD) was used to provide a stress-induced model of IBS in Wistar rats. Colorectal distension (CRD) was used to detect visceral sensitivity, which was evaluated by abdominal withdrawal reflex (AWR) scores. Rats that were confirmed to have visceral hypersensitivity after MD were injected with ghrelin (10 µg/kg) subcutaneously twice a week from weeks 7 to 8. [D-Lys3]-GHRP-6 (100 nmol/L) and naloxone (100 nmol/L) were administered subcutaneously to block growth hormone secretagogue receptor 1α (GHS-R1α) and opioid receptors, respectively. Expression of transient receptor potential vanilloid type 1 (TRPV1) and µ and κ opioid receptors (MOR and KOR) in colon, dorsal root ganglion (DRG) and cerebral cortex tissues were detected by western blotting, quantitative real-time polymerase chain reaction (qRT-PCR), immunohistochemical analyses and immunofluorescence. RESULTS: Ghrelin treatment increased expression of opioid receptors and inhibited expression of TRPV1 in colon, dorsal root ganglion (DRG) and cerebral cortex. The antinociceptive effect of ghrelin in the rat model of IBS was partly blocked by both the ghrelin antagonist [D-Lys3]-GHRP-6 and the opioid receptor antagonist naloxone. CONCLUSION: The results indicate that ghrelin exerted an antinociceptive effect, which was mediated via TRPV1/opioid systems, in IBS-induced visceral hypersensitivity. Ghrelin might potentially be used as a new treatment for IBS.


Asunto(s)
Analgésicos/uso terapéutico , Colon/efectos de los fármacos , Ghrelina/uso terapéutico , Síndrome del Colon Irritable/tratamiento farmacológico , Receptores Opioides/análisis , Canales Catiónicos TRPV/análisis , Dolor Visceral/tratamiento farmacológico , Adulto , Animales , Colon/metabolismo , Colon/patología , Femenino , Ganglios Espinales , Regulación de la Expresión Génica/efectos de los fármacos , Humanos , Síndrome del Colon Irritable/complicaciones , Síndrome del Colon Irritable/genética , Síndrome del Colon Irritable/patología , Masculino , Persona de Mediana Edad , Ratas , Ratas Wistar , Reacción en Cadena en Tiempo Real de la Polimerasa , Receptores Opioides/genética , Canales Catiónicos TRPV/genética , Dolor Visceral/complicaciones , Dolor Visceral/genética , Dolor Visceral/patología
20.
Inorg Chem ; 56(14): 7657-7667, 2017 Jul 17.
Artículo en Inglés | MEDLINE | ID: mdl-28677962

RESUMEN

A facile hydrolysis-coupled redox (HCR) reaction followed by postheating reduction has been designed to prepare unique 3D Cu/Fe3O4 core-shell nanorod array anodes. Fe2+ ions from fresh FeSO4 solution have been hydrolyzed and oxidized to form an Fe(OH)3 shell on the surface of Cu(OH)2 nanorods; meanwhile the resulting acidic environment induces the reduction of Cu(OH)2 to Cu2O, which realizes an unusual redox reaction between Fe2+ ions and Cu(OH)2. The reaction procedure and thermodynamics possibility between Fe2+ ions and Cu(OH)2 nanorod arrays are discussed from the aspect of electrode potentials. After postheating reduction in Ar/H2, the obtained 3D architecture of Cu current collector serves as a stout support for the Fe3O4 shell to form nanorod array anodes without using any binders or conducting agents. The resulting highly stable core-shell structure facilitates rapid and high-throughput transport pathways for ions/electrons and allows better accommodation of volume change during the repeated lithiation/delithiation. Its application as anodes in combination with LiNi0.5Mn1.5O4 cathodes for full cells demonstrates superior rate capability, enhanced energy density, and long cycling life.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA